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ABSTRACT 
Objective: Historically, electrocardiographic (ECG) interpretation criteria for athletes were only 
applicable to adults. New international recommendations now account for athletes ≤16 years, but 
their clinical appropriateness is unknown. We sought to establish the diagnostic accuracy of new 
international ECG recommendations against the Seattle criteria and 2010 European Society of 
Cardiology (ESC) recommendations in paediatric athletes using receiver operator curve (ROC) 
analysis. Clinical context was calculated using Bayesian analysis.  
Methods: 876 Arab and 428 black male pediatric athletes (11-18 years) were evaluated by medical 
questionnaire, physical examination, ECG and echocardiographic assessment. ECGs were 
retrospectively analyzed according to the 3 criteria. 
Results: Thirteen (1.0%) athletes were diagnosed with cardiac pathology that may predispose to 
sudden cardiac arrest/death (SCA/D) [8 (0.9%) Arab and [5 (1.2%) black]. Diagnostic accuracy 
was poor [0.68, 95% CI 0.54-0.82] for 2010 ESC recommendations, fair [0.70, 95% CI 0.54-0.85] 
for Seattle criteria and fair [0.77, 95% CI 0.61-0.93] for international recommendations. False 
positive rates were 41.0% for 2010 ESC recommendations, 21.8% for Seattle criteria, and 6.8% 
for international recommendations. International recommendations provided a positive (+LR) and 
negative (-LR) post-test likelihood ratio of 9.0 (95% CI 5.1-13.1) and 0.4 (95% CI 0.2-0.7), 
respectively.  
Conclusion: In Arab and black male paediatric athletes, new international recommendations 
outperform both the Seattle criteria and 2010 ESC recommendations, reducing false positive rates, 
whilst yielding a ‘fair’ diagnostic accuracy for cardiac pathology that may predispose to SCA/D. 
In clinical context, the ‘chance’ of detecting cardiac pathology within a paediatric male athlete 
with a positive ECG (+LR=9.0) was 8.3%, whereas a negative ECG (-LR=0.4) was 0.4%. 
Key words: Paediatric, athlete’s heart, screening, electrocardiography, echocardiography. 
 
 
  
What is already known about this subject? 
 It has been proposed that electrocardiographic (ECG) screening of athletes is not effective 
due to outdated incidence data and flawed methodology.  
 Recently, new international recommendations for ECG in athletes, have been demonstrated 
to reduce the number of abnormal ECGs, but in a primarily white adult athletic population. 
 It has been proposed that T wave inversion V1-V3 in athletes ≤16 years is physiological, 
and should not prompt further evaluation in the absence of symptoms, signs or a family 
history of cardiac disease. 
What does this study add? 
 For the first time, new international recommendations for ECG interpretation in athletes 
were assessed by diagnostic accuracy and Bayesian analysis in a paediatric athletic cohort 
(aged 11-18 years) of 876 Arab and 428 black male athletes. 
 New international recommendations for ECG interpretation in athletes significantly reduce 
false positive rates for pathology that may predispose to SCA/D (6.8%) irrespective of 
ethnicity and chronological age, compared with the 2010 ESC recommendations (41.0%) 
and Seattle criteria 21.8%), respectively). 
 New international recommendations for ECG interpretation in athletes yield a ‘fair’ (0.77, 
95% CI 0.61-0.93) diagnostic accuracy (area under the curve) for cardiac pathology that 
may predispose to SCD/A in sports. 
How might this impact on clinical practice? 
 The ‘chance’ of detecting cardiac pathology that may predispose to SCA/D in sports within 
a paediatric male athlete was approximately 1%. 
 A positive ECG (+LR = 9.0) as per new international recommendations for ECG 
interpretation in athletes, means that the same athlete now has an 8.3% ‘chance’ of 
pathology, whereas a negative ECG (-LR = 0.4) a 0.4% ‘chance’. 
 New international recommendations for ECG interpretation can be applied to paediatric 
(11-18 years) athletes of both Arab and black athletes for the detection of cardiac pathology 
that may predispose to SCD/A in sports, and outperform previous ECG recommendations. 
 
  
INTRODUCTION 
Studies based on high school populations in the United States reveal that paediatric athletes (14-
18 years) are 3.6-times more likely to experience a sudden cardiac arrest than their non-athletic 
peers [1]. In the United Kingdom, 22% of all sudden cardiac deaths occur in athletes aged under 
18 years [2]. The European Society of Cardiology (ESC) [3] and the Association of European 
Paediatric Cardiology [4], recommend initiating 12-Lead electrocardiography (ECG) screening to 
coincide with the onset of competitive athletic activity. Screening aims to identify underlying 
cardiac pathology predisposing to sudden cardiac arrest/death (SCA/D), and thereby reduce the 
incidence of such catastrophic events.  
 
Until recently clinicians undertaking ECG screening in athletes applied interpretation criteria that 
were applicable only to adults [5,6]. In a recent systematic review with meta-analysis [7], we 
observed a high but similar prevalence of anterior (V1-V3) T-wave inversion (TWI) in ≥9000 
paediatric athletes and ≥800 paediatric non-athletes (6.5% vs 5.7%), suggesting that this 
repolarization pattern is maturational and not abnormal within the paediatric athlete. New ECG 
interpretation recommendations now account for athletes aged ≤16 years, with particular focus on 
individuals displaying anterior (V1-V3) TWI (often called juvenile T-wave pattern) [8–10]. Whilst 
these new recommendations have been shown to significantly reduce the number of abnormal 
ECGs compared to previous ECG criteria [2010 ESC recommendations [5] and Seattle criteria 
[6]], this result was observed in a primarily white adult athletic population [11].  
 
The past few decades have observed an exponential increase in the number of Arab and black 
athletes excelling in international competitive sport, with ethnicity now universally recognized as 
an important determinant of the electrical manifestations of an athlete’s heart [12]. Sports 
academies throughout the USA, Europe and Asia, who undertake ECG screening in paediatric 
athletes of Arab and Black ethnicity require knowledge of the clinical appropriateness of these 
new ECG recommendations to distinguish physiological cardiac adaptations from cardiac 
pathology predisposing to SCA/D.  A second conundrum relates to ensuring that ECG screening 
results are interpreted in context, especially when there is no ‘gold standard’ test to identify cardiac 
pathology. Bayesian analysis allows for the quantification of ‘chance’ of having a disease as per 
examination methodology (in this case, ECG interpretation recommendations), based upon pre- 
and post-test odds [13]. 
 
Accordingly, the aim of this study was to establish the diagnostic accuracy of new international 
ECG interpretation recommendations for athletes against the Seattle criteria and 2010 ESC 
recommendations in a large cohort of Arab and black male paediatric athletes using receiver 
operator curve (ROC) analysis. Clinical context was calculated using Bayesian analysis. 
 
METHODS 
Ethics Approval 
Ethics approval was provided by Anti-Doping Laboratory Qatar (IRB #E2013000003 and 
#E20140000012), with all parents or guardians providing informed consent.  
 
Participants 
Between 2009 and 2017, 876 Arab and 428 black male paediatric athletes registered with the Qatar 
Olympic Committee [exercising ≥6 hours/week, aged 11-18 years] presented at our institution for 
ECG screening. No athlete had been previously screened. Based on 2-year chronological age 
categories, athletes were distributed as per Table 1. Whilst we acknowledge ECG interpretation 
criteria were developed for application in athletes aged 12-35 years [8–10], a minority of athletes 
<12 years presented at the request of the Qatar Olympic Committee. 
 
Preliminary Investigations  
Health questionnaire and physical examination  
Athletes completed a health questionnaire regarding family history of cardiovascular disease and 
personal symptoms, together with anthropometric (height and body mass; body surface area (BSA) 
[14]) and left brachial artery blood pressure assessment in collaboration with an Arabic, French, 
and/or English-speaking nurse. To ensure accurate medical history was taken, primary guardians 
were present where appropriate. Precordial auscultation in supine and standing positions, and 
assessment for any physical characteristics of underlying congenital or syndromal disorder were 
undertaken by a sports medicine physician.  
 
Resting 12-lead ECG  
ECG was recorded with standard 12-lead positions using a GE Mac 5500 (New York, USA), as 
described elsewhere [15]. All 1304 ECGs were retrospectively interpreted by GMC applying the 
2010 ESC recommendations [5], the Seattle Criteria [6], and the new international 
recommendations (Figure 1) [8–10]. At the time of ECG interpretation, GMC was blinded to all 
pathological conditions that were subsequently diagnosed.  
 
Echocardiography  
2D transthoracic echocardiographic examination was performed using a IE33, (Philips, USA) and 
Artida (Toshiba Medical Systems, Japan) ultrasound systems. Standard views were obtained and 
analysed for left and right ventricular wall thickness, cavity dimension measurements, as well as 
the identification of the origins of the left and right coronary arteries in accordance with current 
guidelines [16,17].  
 
Further Evaluation 
Athletes presenting with an abnormal health questionnaire, physical examination, ECG or 
echocardiographic examination suggestive of underlying cardiovascular pathology were invited 
for further evaluation. Subsequent examinations included (but were not limited to) 24h ECG or 
ambulatory blood pressure monitoring, maximal cardiopulmonary exercise stress testing, 
electrophysiology study, computerized tomography and cardiac magnetic resonance imaging 
including contrast studies. Diagnosis of disease was established and managed in accordance to 
established guidelines [18–25].  
 
Statistical Analysis 
Data were expressed as mean ± SD or percentages as appropriate and analyzed with SPSS software 
(Version 21.0, Chicago, IL).  Continuous variables were tested for normality using the Shapiro-
Wilk test. Comparisons between groups were performed using a student t-test for continuous 
variables by ethnicity (Arab vs. black), and χ2 test or Fisher’s exact tests for categorical variables 
by ethnicity (Arab vs. black) and age, both within and between ECG interpretation criteria. A p 
value <0.05 was considered significant. 
 
ROC analysis was used to describe the sensitivity and specificity of the 3 ECG interpretation 
criteria to identify cardiac pathology that may predispose to SCA/D in sports[2]. Area under the 
curve (AUC) represents diagnostic accuracy in differentiating athletes with cardiac pathology; 
interpreted as excellent (>0.90), good (0.80-0.90), fair (0.70-0.80), poor (0.60-0.70), or fail (<0.60) 
[26]. False positives were calculated from the specificity and sensitivity values of the 3 ECG 
interpretation criteria. Bayesian analysis was used to calculate the positive (+LR) and negative 
likelihood ratios (-LR) from the specificity and sensitivity values of the ECG interpretation criteria, 
allowing estimation of the chance of cardiac pathology after application of the 3 ECG 
interpretation criteria. Specifically, the base prevalence rate was determined from the pre-test odds, 
and the +LR and –LR was used to compute the post-test odds [13].  
 
Inter-intra observer variability in ECG interpretation 
Inter- and intra-observer reproducibility for ECG interpretation using the new international 
recommendations, Seattle Criteria and ESC 2010 recommendations were assessed using Cohen κ 
coefficient between two physiologists (GMC, NRR). Data were interpreted as poor (<0.20), fair 
(0.20-0.40), moderate (0.41-0.60), good (0.61-0.80) and very good (>0.80) [27]. A power 
calculation using R package CIBinary determined that 361 athletes were sufficient to detect a 
‘good’ reliability (0.75 95% CI (0.60-0.85) when prevalence of abnormalities was 5.9%. Type 1 
error was 5% and power was set 0.80. Inter- and intra-observer reliability was therefore conducted 
on 400 consecutive independent athletes. Inter-observer reliability for categorizing an ECG as 
abnormal was very good for ESC 2010 recommendations (k=0.85; 95% CI 0.71-0.99), very good 
for Seattle criteria (k=0.90; 95% CI 0.86-0.94), and very good for new international 
recommendations (k=0.90; 95% CI 0.88-0.92). Intra-observer reliability was very good for ESC 
2010 recommendations (k=0.95; 95% CI 0.91-0.99), very good for Seattle criteria (k=0.91; 95% 
CI 0.78-1.00), and very good for new international recommendations (k=0.91; 95% CI 0.78-1.00).  
 
RESULTS 
Demographics 
Arab athletes descended from West-Asia [836; 80.3%], Africa [171; 19.5%], and Europe [2; 
0.2%]. Black athletes descended from Africa [275; 64.2%], West-Asia [139; 32.5%], Central 
America [7; 1.6%], South America [5; 1.2%], and Europe [2; 0.5%]. Athletes participated in 33 
different sports with football (50%) dominating. Mean chronological age (15.9 ± 2.0 vs. 15.2 ± 1.9 
years, p<0.001) was significantly greater in Arab than black athletes, whilst BSA (1.7 ± 0.3 vs 1.7 
± 0.3 m2, p=0.68) was not different (Table 1). 
 
Health questionnaire and physical examination 
 
Overall, 242 (18.6%; 20.2% Arab and 15.2% black) athletes revealed cardiovascular abnormalities 
identified by health questionnaire and/or physical examination. Specifically, 216 (16.6%; 18.3% 
Arab and 13.1% black) athletes self-reported cardiovascular medical issues and 31 (2.4%; 2.1% 
Arab and 3.0% black) athletes demonstrated an abnormal physical examination. 
 
ECG patterns between ethnicity using new international recommendations  
 
Normal and borderline ECG findings 
 
Normal ECG findings were significantly more frequent in black than arab athletes (93.0% vs. 
89.0%; p≤0.001) (Figure 2). TWI in V1-V3 was observed in 69 (16.1%) black athletes compared 
to 56 (6.4%) Arab athletes aged <16 years old (p<0.0001). Borderline ECG findings, either in 
isolation or in association with a recognized training-related ECG finding, were significantly more 
frequent in black than Arab athletes (11.0% vs. 7.4%; p<0.05), with an increased prevalence of 
isolated right atrial enlargement (8.9% vs. 5.1%; p<0.01).  
 
Abnormal ECGs findings  
 
Abnormal ECGs that required further evaluation were more frequent in black than Arab athletes 
(10.5% vs. 6.1%; P<0.01). Specifically, abnormal TWIs were significantly more frequent in black 
than Arab athletes (7.0% vs. 2.1%, p<0.001); with an increased prevalence of both anterior (2.6% 
vs, 1.0%; P<0.05), and lateral (3.3% vs. 1.4%; p<0.05) TWI
. 
Black athletes demonstrated a greater 
prevalence of pathological Q waves than Arab athletes (4.4% vs. 1.6%; p<0.01). Other abnormal 
ECG findings were rarely observed in paediatric athletes (≤1.3%), with no statistical difference 
observed between ethnicity. 
 
Identification of cardiac pathology  
Thirteen (1.0%, 95% CI 0.5-1.7) athletes were diagnosed with pathology that may predispose to 
SCA/D [8 (0.9%, 95% CI 0.4-1.8) Arab and 5 (1.2%, 95% CI 0.4-2.7) black] (Table 2). Of these 
13, 6 (46.2%) demonstrated an abnormal health questionnaire and/or physical examination, 10 
(76.9%) an abnormal ECG according to ESC 2010 recommendations, and 8 (61.5%) an abnormal 
ECG according to both the Seattle Criteria and the new international recommendations.  
 
False positive rates per criteria 
The false positive rate for pathology that may predispose to SCA/D was 41.0% for the 2010 ESC 
recommendations, 21.8% for the Seattle criteria, and 6.8% for the new international 
recommendations (specifically, 5.5% and 9.5% for Arab and black athletes).  
 
Specific false positives per criteria  
Ventricular pre-excitation was a false positive in 7.0% of athletes as per 2010 ESC 
recommendations (short PR interval with/without evidence of delta wave) compared to zero cases 
using the Seattle criteria and new International recommendations (PR interval <120 ms with a 
delta wave (slurred upstroke in the QRS complex) and wide QRS [≥120 ms]). Reclassifying axis 
deviation, atrial enlargement and complete right bundle branch block to be normal when observed 
in isolation or in association with a recognized training-related ECG finding, reduced false positive 
rates from 11.8% and 11.2% using the 2010 ESC recommendations and Seattle criteria, 
respectively, to 0.7% using the new international recommendations (Figure 3, Data Supplement 1-
4). The false positive rate for anterior TWI was 12.8% for 2010 ESC recommendations, 3.0% for 
Seattle criteria and 1.2% for new international recommendations.  
 
Impact of chronological age on false positive rates per criteria 
New international ECG recommendations significantly (p<0.0001) reduced the false positive rate 
for pathology that may predispose to SCA/D compared to the Seattle Criteria and 2010 ESC 
recommendations in athletes aged ≤16 years (6.9% vs. 23.4% vs. 45.6%), ≤14 years (8.7% vs. 
27.9% vs 52.7%), and ≤12 years (8.6% vs 29.3% vs 68.1%), respectively (Figure 4).  
 
Diagnostic accuracy per criteria 
For pathology that may predispose to SCA/D, diagnostic accuracy was poor [0.64, 95% CI 0.47-
0.81] for health questionnaire and/or physical examination, poor [0.68, 95% CI 0.54-0.82] for the 
2010 ESC recommendations, fair [0.70, 95% CI 0.54-0.85] for the Seattle criteria and fair [0.77, 
95% CI 0.61-0.93] for new international recommendations (Figure 5, Table 3).  
 
Clinical implication of using the new international recommendations  
New international recommendations provided an overall +ve and -ve LR of 9.0 (95% CI 5.1-13.1) 
and 0.4 (95% CI 0.2-0.7), respectively. When split by ethnicity, 9.0 (95% CI 3.8-15.8) and 0.5 
(95% CI 0.2-0.8) for Arab, and 8.5 (95% CI 3.8-12.5) and 0.2 (95% CI 0.04-0.7) for black athletes, 
respectively.   
 DISCUSSION  
The correct differentiation of physiological cardiac adaptation owing to sustained and intensive 
exercise from an inherited cardiac pathology is paramount to correctly identify athletes at risk of 
SCA/D. In this study of 876 Arab and 428 black male paediatric athletes, it was observed that new 
international ECG recommendations significantly reduce false positive rates by 83.4% and 68.7% 
respectively when compared to the Seattle criteria and 2010 ESC recommendations, irrespective 
of chronological age, whilst yielding a ‘fair’ diagnostic accuracy for conditions that may 
predispose to SCA/D. To place new international recommendations into clinical context, the 
‘chance’ of detecting cardiac pathology that predispose to SCA/D within a paediatric male athlete 
is approximately 1%. A positive ECG (+LR=9.0) as per new international recommendations, 
means that the same athlete now has an 8.3% ‘chance’ of pathology, whereas a negative ECG (-
LR=0.4) has a 0.4% ‘chance’. 
 
Diagnostic Accuracy of new international recommendations in paediatric Arab and Black 
athletes 
When applying the 2010 ESC recommendations to our athletes, almost 1 in 3 Arab and 1 in 2 black 
athletes would warrant further evaluation, demonstrating a poor (0.68) AUC (diagnostic accuracy). 
The Seattle criteria improved these rates to 1 in 5 Arab and 1 in 4 black athletes, with a fair (0.70) 
overall diagnostic accuracy. While the 2010 ESC recommendations are based upon consensus 
rather than scientific evidence, the Seattle Criteria modified its interpretation criteria by applying 
evidence that 1) accounted for black ethnicity (J-point elevation and convex [‘domed’] ST-
segment elevation followed by TWI in leads V1–V4), a false positive in 6.9% of our black 
paediatric athletes and 2), by adjusting ventricular pre-excitation criteria to require a concomitant 
delta wave (slurred upstroke in the QRS complex) and wide QRS (>120ms) in addition to a short 
PR (<120ms), a false positive in 7.0% of our paediatric athletes.  
 
To further reduce false positive ECG rates and improve diagnostic accuracy, new international 
recommendations now categorize the presence of atrial enlargement (8.9% in our athletes), axis 
deviation (1.9% in our athletes), and complete right bundle branch block (0.4% in our athletes),  
as ‘borderline’ findings when observed in isolation or in association with a recognized training-
related ECG change, as they correlate poorly with cardiac pathology predisposing to SCA/D in 
sport [28,29] (Figure 1). Our data supports these recommendations, by observing 112 athletes 
(8.6%) with isolated borderline ECG findings, and just 9 athletes (0.7%) with ≥2 borderline ECG 
findings that would trigger additional investigation; with none found to have pathology 
predisposing to SCA/D in sports (Figure 2 and 3). False positive rates were again further reduced 
by deeming the juvenile T-wave pattern to be physiological, a false positive in 121 (17.3%) athletes 
aged <16 years compared to 36 (6.1%) athletes ≥16 years. In real terms, when new international 
recommendations are applied to our athletes, 1 in 17 Arab and 1 in 10 black athletes would warrant 
further evaluation, with a fair (0.77) overall diagnostic accuracy [specifically, a fair (0.72) 
diagnostic accuracy for Arab but importantly, a good (0.85) diagnostic accuracy for black athletes]. 
 
Clinical application of new international recommendations in paediatric Arab and Black 
athletes 
Our data confirm that like their adult counterparts (4.9%) [15], a comparable proportion of 
paediatric athletes demonstrate a false positive ECG (6.9%) when utilizing similar ECG criteria; a 
result observed irrespective of chronological age (≤16 years [7.6%] vs. ≤14 years [9.6%] vs. ≤12 
years [8.6%]. This finding is important as the ESC state that ECG screening should start at the 
beginning of competitive athletic activity, which for the majority of sporting disciplines 
corresponds to an age of 12–14 years [30]. Whilst this low false positive rate is reassuring, care is 
warranted however, if considering the sensitivity of ECG screening. Dhutia et al. [11] diagnosed 
15 athletes (from 4,925 screened; 0.3%) with cardiac pathology that may predispose to SCA/D, all 
of whom presented with an abnormal ECG according to new international recommendations (i.e. 
100% sensitivity). We diagnosed 13 athletes with cardiac pathology that may predispose to 
SCA/D, of which just 8 (61.5% sensitivity) had an abnormal ECG according to new international 
recommendations (Table 2). However, the ECG is unable to detect anomalous coronary arteries 
(n=1), aortopathies (n=2) and valvular disease (=1) [8–10], and thus helps explain the reduced 
sensitivity observed. In line with previous literature [31], we confirm that medical questionnaires 
and/or physical examinations were associated with poor sensitivity (46.2%) for conditions 
predisposing to SCA/D. 
 
Bayesian analysis allows for the quantification of ‘chance’ that a patient with an abnormal or 
normal ECG will have a cardiac pathology that may predispose them to SCA/D [13]. As the first 
study to apply Bayesian analysis in any young athletic population, our data demonstrates that 
baseline ‘chance’ of having cardiac pathology predisposing to SCA/D was 1% for the entire cohort. 
The findings presented here show that a positive ECG has a +LR=9.0 meaning that the same athlete 
with a positive test has an 8.3% ‘chance’ of cardiac pathology. Conversely, an athlete with a 
negative ECG (-LR=0.4) would have an 0.4% chance. Our analysis also demonstrate that the new 
international recommendations provide a greater positive likelihood (+LR=9.0) compared to the 
2010 ESC recommendations (+LR=1.9) and the Seattle Criteria (+LR=2.7), respectively (Table 
3).  
 
Limitations 
Our results are based on observational cross-sectional data, and thus we may have underestimated 
prevalence of cardiac pathology that may predispose to SCA/D in sport, since it is recognized that 
gene carriers of inherited cardiac pathology may not exhibit phenotype evidence until early 
adulthood. Secondly, our population were exclusively Arab and black male athletes, limiting 
application to other ethnicities and the female paediatric athlete. Finally, whilst we only recruited 
athletes who were registered with the Qatar Olympic Committee exercising ≥6 hours/week, we 
did not define fitness (such as aerobic capacity).  
 
Conclusion 
In conclusion, new international ECG interpretation recommendations for athletes outperform 
both the Seattle criteria and 2010 ESC recommendations by reducing false positive rates in Arab 
and black paediatric male athletes, whilst yielding a ‘fair’ diagnostic accuracy for conditions that 
may predispose to SCA/D in sports Interpretation of the paediatric athletes ECG by new 
international recommendations provides the best likelihood of triggering further evaluation in the 
attempt to detect cardiac pathology.  
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TABLES 
Table 1. Anthropometric data of pediatric athletes  
Age group 
(years.) 
Group n % Height (cm) Body mass (kg) BSA (m2) 
11-12 Total 117 9.0 152.8 ± 9.4 45.2 ± 11.0 1.38 ± 0.20 
 Arab 91  151.1 ± 8.5 44.3 ± 9.5 1.36 ± 0.17 
 Black 26  158.5 ± 10.4** 48.5 ± 15.1 1.45 ± 0.26† 
13-14 Total 5410 31.4 167.9 ± 9.5 58.3 ± 13.8 1.6 ± 0.23 
 Arab 204  166.6 ± 9.7 58.1 ± 15.9 1.63 ± 0.25 
 Black 206  169.2 ± 9.1* 58.6 ± 11.5 1.66 ± 0.19 
15-16 Total 351 26.9 174.9 ± 9.6 67.3 ± 16.4 1.80 ± 0.25 
 Arab 261  174.1 ± 8.6 66.7 ± 16.6 1.79 ± 0.25 
 Black 90  177.2 ± 11.8** 69.0 ± 15.9 1.83 ± 0.25 
17-18 Total 426 32.7 177.2 ± 8.6 70.5 ± 14.3 1.86 ± 0.22 
 Arab 320  176.7 ± 8.0 70.4 ± 14.0 1.86 ± 0.12 
 Black 106  178.6 ± 10.3 70.8 ± 15.2 1.87 ± 0.23 
Values are mean ± standard deviation. 
* p≤0.01, significantly more prevalent or greater in black than Arab athletes 
*** p≤0.001, significantly more prevalent or greater in black than Arab athletes 
† p≤0.01, significantly more prevalent or greater in Arab than black athletes 
BSA, Body surface area. 
 Table 2. Characteristics of athletes diagnosed with cardiac pathology that may predispose to sudden cardiac death in sports. 
Pathology Age Ethnicity Sport H + P 
Abnormality 
ECG 
Abnormality 
ESC 
2010 
Seattle International Diagnostics Risk 
Stratification 
Anomalous origin of left 
coronary artery 
 
15 Arab Football Nil Short PR 
interval 
+ - - Echo, 
CMRI, CT 
EST, Holter 
ARVC 
 
 
 
18 Black Football Family history 
of 
cardiomyopathy 
TWI V2-V6 
 
+ + + Echo, 
CMRI 
EST, Holter 
Aneurysm with aortic root 
dilatation (Z score 4) 
 
 
12 Arab Football Nil Nil - - - Echo, 
CMRI, CT 
Gene Test 
Aortic coarctation with aortic 
root dilatation (moderate 
[Valsalva Sinus – Z Score 
3.06] to mild [ascending 
aorta – Z score 2.98]), BAV 
and moderate PR 
 
 
18 Arab Football Murmur Nil - - - Echo, 
CMRI, 
Angiogram 
EST 
HCM 
 
 
 
 
 
13 Black Football Nil TWI 
AVL, V2-V5 
 
Q waves 
II, III, AVF, 
V5, V6 
 
+ + + Echo, 
CMRI 
EST, Holter, 
Gene Test 
LVNC 13 Black Football Nil TWI 
II, III, AVF, 
V1-V6 
 
Q waves 
II, III, AVF, 
V4 -V6 
 
+ + + Echo, 
CMRI 
EST, Holter, 
Gene Test 
MVP with severe MR, 
necessitating surgical repair 
 
18 Black 800m 
runner 
Murmur 
Chest Pain 
Nil - - - Echo - 
Myocarditis, with 
anterolateral, lateral and 
inferolateral mid-wall 
fibrosis at basal level. 
 
14 Arab Football Nil TWI V1-V3 + + - Echo, 
CMRI 
EST, Holter 
Myocarditis, with 
anterolateral, lateral and 
inferolateral mid-wall 
fibrosis at basal and mid 
ventricular level. 
 
13 Arab Golf Family history 
of 
cardiomyopathy 
TWI AVL, 
V1 
V4-V5 
 
+ + + Echo, 
CMRI 
EST, Holter 
Myocarditis, with 
anterolateral and lateral mid-
wall fibrosis at basal level. 
 
16 Arab Football Syncope TWI 
III, AVF, 
V1, V4-V6 
 
+ + + Echo, 
CMRI 
EST, Holter 
SVT with re-entry 
 
 
  
14 Arab Football Nil Short PR 
interval 
PVCs 
+ + + Echo, 
CMRI 
EST, Holter, 
EPS 
WPW 
 
 
 
 
13 Arab Swimmer Nil Short PR 
interval 
Delta Wave 
Wide QRS 
+ + + Echo EST, Holter, 
EPS 
WPW 13 Black Football Family history 
of SCA/D 
Short PR 
interval 
Delta Wave 
Wide QRS 
TWI 
AVL, V1-V4 
 
+ + + Echo, 
CMRI 
EPS 
ARVC; arrhythmogenic right ventricular cardiomyopathy; BAV; bicuspid aortic valve; CMRI; Cardiac Magnetic Resonance Imaging; ECG; 12-lead 
electrocardiogram; EST; Exercise Stress Testing; H + P = history and physical examination; HCM; hypertrophic cardiomyopathy; LVNC, left ventricular non-
compaction; MVP; Mitral Valve Prolapse; MR; mitral regurgitation; PR; pulmonary regurgitation; SCA/D, sudden cardiac death; SVT, supraventricular 
tachycardia; TWI, T-wave inversion; WPW; Wolf-Parkinson-White syndrome. 
  
 Table 3: Positive and Negative likelihood ratios of three ECG interpretation criteria to detect cardiac pathology that may predispose to sudden cardiac 
death/arrest only 
 Combined Athletes (n=1304) Arab Athletes (n=876) Black Athletes (n=428) 
 ESC 2010 Seattle 
Criteria 
International 
Criteria 
ESC 2010 Seattle 
Criteria 
International 
Criteria 
ESC 2010 Seattle 
Criteria 
International 
Criteria 
Sensitivity,% 76.9 
(46.2-95.0) 
 
61.5  
(31.6-86.1) 
61.5  
(31.6-86.1) 
75.0 
(34.9-96.8) 
50.0 
(15.7-84.3) 
50.0 
(15.7-84.3) 
80.0 
(28.4- 99.5) 
80.0  
(28.4-99.5) 
80.0 
(28.4-99.5) 
Specificity, % 59.0 
(56.3-61.7) 
 
78.2 
(75.9-80.5) 
93.2 
(91.7-94.5) 
62.4 
(59.1-65.7) 
79.7  
(76.9-82.4) 
94.5  
(92.7-95.9) 
52.0 
(47.1-58.9) 
75.2 
(70.8-79.2) 
90.5  
(87.4-93.2) 
AUC 0.68 
(0.54-0.82) 
 
0.70 
(0.54-0.85) 
0.77 
(0.61-0.93) 
0.69 
(0.51-0.86) 
0.65 
(0.44-0.86) 
0.72 
(0.50-0.94) 
0.66 
(0.44-0.88) 
0.77 
(0.57-0.98) 
0.85 
(0.65-1.00) 
+ve likelihood 
ratio 
1.9   
(1.2-2.3) 
 
2.7   
(1.6-3.9) 
9.0 
(5.1-13.1) 
2.0 
(1.1- 2.5) 
2.5 
(1.1-4.0) 
9.0 
(3.8-15.8) 
1.7 
(0.8-2.1) 
3.2 
(1.5-4.3 
8.5 
(3.8-12.5) 
-ve likelihood 
ratio 
0.4  
(0.1-0.9) 
 
0.5 
(0.2-0.8) 
0.4   
(0.2-0.7) 
0.4   
(0.1- 0.9) 
0.6 
(0.3-1.0) 
0.5  
(0.2-0.8) 
0.4 
(0.07-1.2) 
0.3 
(0.05-0.8) 
0.2 
(0.04-0.7) 
+ve post-test 
chance of 
pathology, % 
1.9  
(0.9-3.4) 
2.7  
(1.2-5.3) 
8.3  
(3.3-14.3) 
1.8  
(0.7- 3.9) 
2.3  
(0.6-5.6) 
7.7  
(2.1-18.2) 
2.0 
(0.5-4.8) 
3.8 
(1.0-8.8) 
8.1 
(2.1-18.2) 
-ve post-test 
chance of 
pathology, % 
0.4 
(0.08-1.2) 
 
0.5 
(0.2-1.2) 
0.4 
(0.1-1.0) 
0.4 
(0.04-1.3) 
0.5 
(0.2-1.5) 
0.5 
(0.1-1.2) 
0.5 
(0.01-2.5) 
0.4 
(0.0-1.8) 
0.2 
(0.0-1.5) 
Data are presented as % (95 % CI) 
AUC, area under the curve; +ve, positive; -ve, negative. 
 
FIGURES 
 
 
Figure 1. International recommendations for electrocardiographic interpretation in athletes 
Key: AV; atrioventricular LBBB; left bundle branch block; LVH, left ventricular hypertrophy; ms; milliseconds; PVCs, premature 
ventricular contractions; RBBB; right bundle branch block; RVH; right ventricular hypertrophy; RBBB; right bundle branch block.
  
Figure 2. Prevalence of normal, borderline and abnormal ECG findings by chronological age group for Arab and black pediatric athletes 
according to International recommendations.  
Key: Data are presented as n (%)  
 Figure 3. Bar chart shows specific ECG false positives rates with reference to to the 3 ECG interpretation criteria. 
 Figure 4. Bar chart shows percentage of false positive ECG findings according to the 3 ECG interpretation criteria by chronological 
age. *P <0.05, Significantly reduced prevalence to ESC 2010 recommendations. # P <0.05, Significantly reduced prevalence to Seattle 
Criteria.  
  
Figure 5. Receiver-operating curves according to health questionnaire and/or physical examination and the 3 ECG interpretation 
criteria to detect cardiac pathology that may predispose to sudden cardiac death/arrest. 
